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Abstract. A mouse melanoma model was set up with
green fluorescent protein (GFP) expression in vivo. With the
same energy, long- (1 ms) and short- (300 ns) pulsed
electric fields were delivered to two melanomas injected
into the same mouse. The tumor growth and green
fluorescence were followed up to compare the different
treatment efficacy of long and short pulses. After two days
post treatment, short pulse-treated tumors showed a
significantly lower tumor volume compared with long
pulse-treated tumors (n=8, p<0.05). On 8 experimental
animals, a short nanosecond pulsed electric field (nsPEF)
had lesser or delayed effects on GFP quenching and
greater effects in reducing tumor size. Short pulses
produced by nsPEFs can cause melanoma regression with
less effect on the plasma membrane. 
A nsPEF is a chemical-free, non-ionizing physical therapy
emerging recently for cancer treatment (1), but few in vivo
studies have been done to confirm the treatment efficacy.
Furthermore, differences between short- and long-pulsed
electric fields have been unknown to this present time. 
To test nsPEFs’ anti-tumor in vivo effect and further
compare the difference between the long- and short-pulsed
fields, our current project designed a fluorescent tumor
model in mice to measure regression in melanoma treated by
short- (300 ns) and long-pulse (1 ms) electric fields.
Materials and Methods
Αnimal study. In vivo experiments were set up in conformity with
IACUC guidelines under applicable international laws and policies
(Animal Care and Use Committee of Eastern Virginia Medical
School IACUC #04-011, #04-013). B16F10 melanoma cells were
transfected with GFP and kept in the Frank Reidy Research Center
for Bioelectrics (FRRCBE, Norfolk, VA, USA). The cells were
implanted subcutaneously in the right and left flank of eight SKH-
1 female mice (CharlesRiver,Wilmington, MA, USA).
Electric conditions for nanosecond pulse and millisecond pulse.
Pulses were generated using 40 kV/cm, with a rise time of
approximately 30 ns by a Blumlein pulse generator designed and
assembled at the Frank Reidy Research Center for Bioelectrics
(Norfolk, VA, USA). The 5-needle electrode was also designed and
produced by Frank Reidy Research Center for Bioelectrics as
previously described (2). The outer needles were electrically
connected to ground (cathode) while the center needle delivered the
positive high-voltage pulse (anode). Identical electric energy was
delivered to 2 tumors developed on the left and right flanks of the
same mouse. One tumor was treated with long- (1 ms, 150 V, 48
pulses) the other with short-pulse (300 ns, 6 kV 100 pulse) electric
field. 
Fluorescent tumor model. Five days after the subcutaneous injection
of 1×106 B16F10 GFP cells, tumors had a mean diameter of 5 mm
and were treated. With GFP expression, the melanomas were clearly
detected under the animal’s skin upon fluorescence microscopy.
Sample collections and analysis. 0, 1, 3, 6, 24 and 72 hours after
treatment, tumors were viewed and photographed using an inverted
fluorescence microscope with a high-quality narrow band GFP filter
(Chroma Technology Corp., Brattleboro, VT, USA). Quantification
of the fluorescence intensity of GFP was analyzed using analySIS
software (Soft Imaging System GmbH, Muenster, Germany). Tumor
volume was calculated as described in (3): V=0.52×D12×D2, where
D1 and D2 are short and long tumor diameters measured by
tranillumination and surface photography.
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Statistical analysis. Results were presented as the mean±SE and
were evaluated using Students t-test. A p-value of less than 0.05 was
considered statistically significant.
Results
Comparison of long- and short-pulse electric fields. Before
pulses were delivered, tumors had bright green fluorescence.
When the 1-ms PEF (150 V, 48 pulses) was applied to the tumor,
GFP quenching occurred immediately (Figure 1). In contrast,
when the 300-ns PEF (6 kV, 100 pulses) was applied to the
tumor, the GFP began to fade gradually (Figure 2). After 3-6
hours, most of the green fluorescence had disappeared. After 24
hours post-nsPEF treatment the fluorescence had comletely
vanished. Both long and short pulses had quenching effects on
GFP fluorescence, but long-pulse effects were immediate,
suggesting a direct effect on GFP fluorescence. In contrast, short-
pulse effects on quenching were delayed and coincident with
apoptosis, suggesting that GFP degraded with other proteins in
response to apoptosis. Furthermore, short pulse conditions
inhibited tumors more effectively than longer pulse conditions.
in vivo 25: 23-28 (2011)
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Figure 1. Long-pulse effects on fluorescent melanoma tumor cells in vivo. Digital imaging was used to quantify the relative fluorescence of B16F10
GFP tumors at different time points. The images show GFP fluorescence at times between 1-180 minutes. The surface view and the dissected view
are also shown over the same time course. Scale bar is 2 mm. 
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After two days post treatment, short-pulse-treated tumors
showed a significantly lower tumor volume compared with
long-pulse- treated tumors (Figure 3) (n=8, p<0.05).
Discussion
Melanoma cancer is now the leading cause of death amoung
skin diseases. Solid tumors develop from malignant
transformation of melanocytes which are specialized
pigmented cells residing in the epidermal basement membrane
of the skin (4). Malignant melanoma is a very aggressive
disease with a high metastatic rate and very poor overall
prognosis. The median survival rate is 6 months and the 5-year
survival rate is below 5%. Deaths have increase 15-fold over
the past four decades according to the epidemiological data
from the American Cancer Society’s website (5).
Melanoma has traditionally been approached systemically
with chemotherapy, or locally with either surgery or
radiotherapy. Researchers have recognized the lack of effective
therapies and are looking for improved treatments. Electric
fields produce a proven physical effect on the cell membrane.
Theese fields serve as a chemical-free, non-ionizing physical 
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Figure 2. Short-pulse effects on fluorescent melanoma tumor cells in vivo. Digital imaging was used to quantify the relative fluorescence of B16F10
GFP tumors at different time points. The images show GFP fluorescence at times between 1-72 hours. Surface views, dissected views, and
transillumination views are also shown over the same time course. Scale bar is 2 mm.
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therapy that may trigger apoptosis by a different mechanism or
pathway (6). The recent development of pulsed electric fields
produce unique characteristics that may solve the problems
caused by over heating. Nanosecond-pulsed electric field
treatment utilizes high electric fields (kV/cm) applied for ultra-
short durations (ns). Quite different from classical plasma
membrane electroporation, nsPEFs can produce highly
compressed power (billions of watts), of ultra-short pulse
durations (ns), rapid rise times (ns), with the high electric fields
(kV/cm). The resulting nanosecond pulse is so short that it can
penetrate into the cell before the plasma membrane is fully
charged, allowing nsPEF to have minimal affect on the plasma
membrane, therefore not causing electroporation (7). 
Production of nsPEFs has not only had military, but also
biological applications creating a new field: Bioelectrics, i.e.
using ultra-short pulsed electric fields on living cells, tissues,
and even organs. This new burgeoning branch of research
analyzes how biological systems react to high electric fields
applied with very short-pulse nanosecond duration. Applied
in fighting against bacteria, nsPEFs have demonstrated
decontamination potential. Only in recent years have nsPEFs
been applied to mammalian cells following careful modeling
research and studies using non-mammalian cultured cells (6).
The main characteristics of nsPEFs are their high power and
low energy leading to very little heat production and their
ability to enter the cell to penetrate intracellular organelles
(8). nsPEF are unique because of their non-electroporation
effect on the plasma membrane (9).
Recently, a number of studies have been carried out to
determine biological effects of nsPEF in cultured cells. The
results showed that nanosecond pulse stimulation of a variety
of cells produces a wide range of physiological responses.
Cells treated by nsPEF in vitro studies include: p53 wild-type
and p53-null HCT116 (human colon carcinoma) (10); HL-60
(human promyelocytic leukemia) (11); Jurkat (human
peripheral blood, leukemia) (12); B16F10 (murine melanoma)
(13) and BS-LCL (human B-cell lymphoblastoid line from a
patient with bloom syndrome) (14). 
Effects of nsPEFs on cells in vitro include: apparent direct
electric field effects; induced apoptosis leading to caspase
activation and then cell death; nuclear changes and modified
cellular functions with delayed plasma membrane effects
becoming smaller as the pulse duration is shortened; release of
calcium from internal calcium pools and activation of plasma
membrane calcium influx channels or capacitative calcium entry
(like ligand-mediated responses); induction of DNA and cell
cycle anomalies; and diminished cell survival. The biological
effect of nsPEFs on cells in vitro is directly related to the electric
field strength, the pulse number and the pulse duration.
The effect of nsPEF treatment on multicellular tissue or
human patients was not tested until very recently. An ex vivo
study on mouse embryonic fibroblasts was the initial
approach for testing nsPEF effects on tissues. Fibrosarcoma
tumors (B10.2) were injected in the flanks of C57Bl/6 mice
and then excised and exposed to nsPEF. Fibrosarcoma B10.2
cells ex vivo became reduced in size after nsPEF treatment
(15). Because the tumors were removed from the animals
before therapy then sliced and exposed to nsPEF in cuvettes,
the experiment was ex vivo rather than in vivo. Therefore, the
data cannot substitute for an in vivo experiment.
Based on the previous in vivo and ex vivo work, nsPEF
treatment is hypothesized as a highly localized, drug-free,
non-thermal physical technique which would be a new
therapy for tumor treatment. To apply nsPEF to tumors in
vivo is an important bridge to relate the individual in vitro
cellular response with future clinical application. This
emerging field has many unknowns surrounding the nsPEF
mechanism of actions on tumors in vivo.
In the current study, the same total energy was delivered to
two tumors on the same mouse. One treatment was long pulse
(150 V, 1 ms, 48 pulses) and the other was short pulse (6 kV,
300 ns, 100 pulses). The energy administered is given by: 
where W is the energy (joules), τ is the pulse duration, V is
the voltage across the electrodes (volts), R is the tissue
resistance (Ω), and N is the pulse number. Although there is
not an absolute value of energy, for long pulses (1 ms) at a
lower voltage (150 V), 48 pulses were calculated as
delivering the same energy to the tissue as 100 short pulses.
This was based on differences between the electrodes used. 
Several interesting effects were observed in the study of
conventional plasma membrane electroporation pulses defined
in vivo 25: 23-28 (2011)
26
Figure 3. Tumor volume and GFP fluorescence changes before and after
PEF treatment. Effects of long and short pulses on tumor volume and
GFP fluorescence as a function of time after pulse treatment are shown
as indicated in the color code (n=8, p<0.05). The long and short pulses
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as long pulses and nsPEF pulses as described as short pulses.
The first observation was that decreases in tumor volumes
occured on both long- and short-pulsed treatment. However,
the application of short pulses resulted in greater tumor size
decreases than those observed for long pulses. This indicates
that nsPEF treatment of tumors is different from conventional
electroporation pulse treatment and is thus more effective.
Long pulses are known to have predominant effects on the
plasma membrane, with few or no effects on the intracellular
membrane (16). In contrast, for shorter pulses, as the pulse
duration decreases, greater effects occur on intracellular
organelles and membranes (16). Nevertheless, short pulses have
effects on the plasma membrane creating nanopores in a
process termed supra-electroportation. These nanopores are
much smaller (~1 nm) and more numerous than larger pores
formed by classical plasma membrane electroporation pulses
or longer pulses. For 300 ns pulses it is not clear where this
condition fits into the paradigms of plasma membrane or
intracellular membrane effects. Based on in vitro effects of long
and short pulses on propidium iodide (PI) uptake in Jurkat cells
(16), 60 ns pulses had significantly delayed effect on PI uptake
compared to 300 ns pulses, suggesting the absence of direct
effects on plasma membranes with shorter pulses. In addition,
PI may be too large a molecule to enter nanopores caused by
supra-electropoation. For 300 ns pulses, there were immediate
effects as well as delayed effects on PI uptake, suggesting a
mixture of classical plasma membrane electroporation and
supra-electroporation. In contrast, 10- and 100-μs pulses caused
immediate PI uptake, suggesting conventional electroporation
effects. It should be noted that effects of these pulses in vitro
and in vivo may be different and that pulses in the referenced
study were not corrected for energy density. Nevertheless, this
provides an initial understanding of differences between
conventional plasma membrane electroporation and nsPEFs
yielding this supra-electroporation event.
A second interesting observation was made regarding
effects of long and short pulses on GFP fluorescence. The
long pulses had immediate effects on GFP, causing rapid
quenching effect within minutes. This suggests a direct effect
of the long pulses on GFP fluorescence (quenching). 
In summary, long and short pulses differ in their effects
on tumor growth and GFP fluorescence quenching). Short
nsPEF pulses have lesser and/or delayed effects on GFP
quenching and greater effects in decreasing in tumor size.
Nanosecond pulses have less effect on the plasma membrane
and may have a role in cancer therapy. 
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